Novome Biotechnologies, Inc. — Form D
Novome Biotechnologies, Inc. of DALY CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-10. The offering totals $700K, of which $536K was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-01-10
- Form: D
- Accession: 0001694013-17-000001
- Industry: Other Technology
- Exemptions: 04, 05, 06b
- Total offering: $700K
- Amount sold: $536K
- Remaining: $164K
- Investors: 10
- Date of first sale: 2016-11-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278006
Issuer
- Name: Novome Biotechnologies, Inc.
- CIK: 0001694013
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 15 WESTMONT DRIVE, DALY CITY, CA, 94015
- Phone: 650-416-6863
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| William DeLoache | Director | Daly City, CA |
| Samuel Smits | Director | Daly City, CA |
| Elizabeth Stanley | Director | Daly City, CA |
| Weston Whitaker | Director | Daly City, CA |
| Weston Whitaker | Executive Officer | Daly City, CA |
| Weston Whitaker | Promoter | Daly City, CA |
More